FDA warns about safety risks of tailored weight-loss drugs

(Reuters) – The U.S. Food and Drug Administration (FDA) warned about the safety risks of using compounded or custom-made versions of popular weight-loss drugs such as Wegovy and diabetes drug Ozempic. The health regulator on Wednesday said it had received reports of adverse events after patients used compounded versions of semaglutide, the active ingredient in…

Read More

What makes us human? Primate genome study offers some clues

By Will Dunham WASHINGTON (Reuters) – The most comprehensive genomic study ever on primates – a group whose membership includes lemurs, monkeys, apes and people – has revealed pivotal genetic traits that are uniquely human while refining the timeline for our evolutionary lineage’s split from our closest cousins, the chimpanzees and bonobos. Researchers said on…

Read More

Explainer-Can a New York state law solve or trigger an emerging markets debt crisis?

By Rodrigo Campos and Jorgelina do Rosario NEW YORK/LONDON (Reuters) -A bill backed by debt justice campaigners and civil society groups advocating on behalf of economically distressed countries could alter past and future sovereign debt restructurings covered by New York state law – and Wall Street is watching. With a week left in this year’s…

Read More

LatAm property tech unicorn Tuhabi lands $50 million credit line from development bank

By Kylie Madry MEXICO CITY (Reuters) – Latin American property technology startup Tuhabi is set to receive a $50 million credit line from the Inter-American Development Bank’s (IDB) financing arm, which it will use to ramp up operations in Mexico, the company said Thursday. The funds for the so-called unicorn, a startup with a valuation…

Read More

Goldman Sachs to cut more jobs, eyes sharp fall in markets revenue

By Saeed Azhar and Niket Nishant NEW YORK (Reuters) -Goldman Sachs Group Inc plans to cut more jobs as a difficult economic environment weighs on dealmaking and trading revenue may slump 25% this quarter, the bank’s president said on Thursday. “The macro backdrop is extraordinarily challenging,” Goldman’s president and chief operating officer, John Waldron, told…

Read More